A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.
The genetic factors associated with susceptibility to nonalcoholic fatty liver disease (NAFLD) in pediatric obesity remain largely unknown. Recently, a nonsynonymous single-nucleotide polymorphism (rs738409), in the patatin-like phospholipase 3 gene (PNPLA3) has been associated with hepatic steatosis in adults. In a multiethnic group of 85 obese youths, we genotyped the PNLPA3 single-nucleotide polymorphism, measured hepatic fat content by magnetic resonance imaging and insulin sensitivity by the insulin clamp. Because PNPLA3 might affect adipogenesis/lipogenesis, we explored the putative association with the distribution of adipose cell size and the expression of some adipogenic/lipogenic genes in a subset of subjects who underwent a subcutaneous fat biopsy. Steatosis was present in 41% of Caucasians, 23% of African Americans, and 66% of Hispanics. The frequency of PNPLA3(rs738409) G allele was 0.324 in Caucasians, 0.183 in African Americans, and 0.483 in Hispanics. The prevalence of the G allele was higher in subjects showing hepatic steatosis. Surprisingly, subjects carrying the G allele showed comparable hepatic glucose production rates, peripheral glucose disposal rate, and glycerol turnover as the CC homozygotes. Carriers of the G allele showed smaller adipocytes than those with CC genotype (P = 0.005). Although the expression of PNPLA3, PNPLA2, PPARγ2(peroxisome proliferator-activated receptor gamma 2), SREBP1c(sterol regulatory element binding protein 1c), and ACACA(acetyl coenzyme A carboxylase) was not different between genotypes, carriers of the G allele showed lower leptin (LEP)(P = 0.03) and sirtuin 1 (SIRT1) expression (P = 0.04).


CONCLUSIONS
A common variant of the PNPLA3 gene confers susceptibility to hepatic steatosis in obese youths without increasing the level of hepatic and peripheral insulin resistance. The rs738409 PNPLA3 G allele is associated with morphological changes in adipocyte cell size.
Santoro
Nicola
N
Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.
Kursawe
Romy
R
D'Adamo
Ebe
E
Dykas
Daniel J
DJ
Zhang
Clarence K
CK
Bale
Allen E
AE
Calí
Anna M
AM
Narayan
Deepak
D
Shaw
Melissa M
MM
Pierpont
Bridget
B
Savoye
Mary
M
Lartaud
Derek
D
Eldrich
Samuel
S
Cushman
Samuel W
SW
Zhao
Hongyu
H
Shulman
Gerald I
GI
Caprio
Sonia
S
D000273:Adipose Tissue / Q000166:cytology; D000293:Adolescent; D048429:Cell Size; D002648:Child; D005234:Fatty Liver / Q000235:genetics* / Q000473:pathology; D005260:Female; D015870:Gene Expression; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008049:Lipase / Q000235:genetics*; D008099:Liver / Q000378:metabolism; D008297:Male; D009765:Obesity / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D000217:Acyltransferases
D008049:Lipase; C494794:PNPLA2 protein, human; D000217:Acyltransferases
Fed Proc. 1970 Jul-Aug;29(4):1516-21
5459900
Lancet. 2003 Sep 20;362(9388):951-7
14511928
Hepatology. 2010 Feb;51(2):679-89
20041406
J Biol Chem. 2001 Sep 7;276(36):33336-44
11431482
N Engl J Med. 2002 Apr 18;346(16):1221-31
11961152
Dig Dis Sci. 1995 Sep;40(9):2002-9
7555456
Endocrinol Metab Clin North Am. 2009 Sep;38(3):549-63
19717004
Diabetes Care. 1999 Sep;22(9):1462-70
10480510
Diabetes. 2009 Nov;58(11):2616-23
19651814
J Clin Invest. 2007 Mar;117(3):739-45
17318260
Int J Obes (Lond). 2010 Jan;34(1):190-4
19844213
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9793-8
18599449
J Clin Endocrinol Metab. 2004 Jun;89(6):2684-9
15181042
Hepatology. 2009 Jun;49(6):1896-903
19434725
Diabetes. 2006 Mar;55(3):826-33
16505250
J Lipid Res. 2009 Oct;50(10):2111-6
19738004
Magn Reson Med. 2008 Mar;59(3):521-7
18306404
Magn Reson Imaging. 1997;15(3):287-93
9201675
Mol Cell Endocrinol. 2009 Nov 13;311(1-2):39-46
19619606
Cell Metab. 2005 Jul;2(1):55-65
16054099
Nature. 2004 Jun 17;429(6993):771-6
15175761
Diabetologia. 2009 Jun;52(6):1056-60
19224197
Pediatrics. 2006 Oct;118(4):1388-93
17015527
J Clin Endocrinol Metab. 2004 Mar;89(3):1096-101
15001593
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17075-80
17940018
J Clin Invest. 2006 Mar;116(3):817-24
16485039
J Biol Chem. 2010 Feb 26;285(9):6706-15
20034933
Nat Genet. 2008 Dec;40(12):1461-5
18820647
Cell Metab. 2007 Jul;6(1):69-78
17618857
Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R112-9
15001430
J Biol Chem. 2004 Nov 19;279(47):48968-75
15364929
Hepatology. 2010 Apr;51(4):1209-17
20373368
PLoS Comput Biol. 2009 Mar;5(3):e1000324
19325873
J Biol Chem. 2000 Mar 24;275(12):8456-60
10722680
J Hepatol. 2010 Aug;53(2):335-8
20546964
Gut. 2009 Nov;58(11):1538-44
19625277
J Biol Chem. 2004 Jul 30;279(31):32345-53
15166226
J Lipid Res. 2005 Nov;46(11):2477-87
16150821
J Cell Biochem. 2008 Dec 15;105(6):1430-6
18980248
Diabetes. 1987 Aug;36(8):914-24
3297886
Diabetologia. 2007 Aug;50(8):1707-15
17549449